BDSX Q4 2020 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$27M+226.8% YoY

Gross Profit

$12M45.8% margin

Operating Income

-$3M-9.8% margin

Net Income

-$5M-16.8% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+194.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$121M

Total Liabilities

$80M

Stockholders' Equity

$41M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$8M	+226.8%
Gross Profit	$12M	$6M	+92.2%
Operating Income	-$3M	-$4M	+25.1%
Net Income	-$5M	-$7M	+30.5%

Revenue Segments

Diagnostic Tests

$32M89%

Service

$4M11%